The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Alekseeva T.M.

Almazov National Medical Research Center

Vlasenko A.I.

Almazov National Medical Research Center

Demeshenok V.S.

Almazov National Medical Research Center

Pavlova T.A.

Almazov National Medical Research Center

Smirnova A.Yu.

Almazov National Medical Research Center

Fomicheva Yu.V.

Almazov National Medical Research Center

Kostareva A.A.

Almazov National Medical Research Center

Phenotypic heterogeneity of Charcot–Marie–Tooth type 2A disease associated with the c.1091G>C missense mutation (p.Arg364Pro) in the MFN2 gene

Authors:

Alekseeva T.M., Vlasenko A.I., Demeshenok V.S., Pavlova T.A., Smirnova A.Yu., Fomicheva Yu.V., Kostareva A.A.

More about the authors

Read: 468 times


To cite this article:

Alekseeva TM, Vlasenko AI, Demeshenok VS, Pavlova TA, Smirnova AYu, Fomicheva YuV, Kostareva AA. Phenotypic heterogeneity of Charcot–Marie–Tooth type 2A disease associated with the c.1091G>C missense mutation (p.Arg364Pro) in the MFN2 gene. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(5):125‑130. (In Russ.)
https://doi.org/10.17116/jnevro2025125051125

References:

  1. Morena J, Gupta A, Hoyle J. Charcot-Marie-Tooth: From Molecules to Therapy. Int J Mol Sci. 2019;20(14):3419. https://doi.org/10.3390/ijms20143419
  2. Timmerman V, Strickland A, Züchner S. Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success. Genes (Basel). 2014;5(1):13-32.  https://doi.org/10.3390/genes5010013
  3. Pisciotta C, Bertini A, Tramacere I, et al. Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: Data from the National CMT Registry. Eur J Neurol. 2023;30(8):2461-2470. https://doi.org/10.1111/ene.15860
  4. Fridman V, Bundy B, Reilly M, et al. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry. 2015;86(8):873-878.  https://doi.org/10.1136/jnnp-2014-308826
  5. Chandhok G, Lazarou M, Neumann B. Structure, function, and regulation of mitofusin-2 in health and disease. Biol Rev Camb Philos Soc. 2018;93(2):933-949.  https://doi.org/10.1111/brv.12378
  6. Filadi R, Pendin D, Pizzo P. Mitofusin 2: from functions to disease. Cell Death Dis. 2018;9(3):330.  https://doi.org/10.1038/s41419-017-0023-6
  7. Beręsewicz M, Charzewski Ł, Krzyśko K, et al. Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity. Sci Rep. 2018;8(1):16900. https://doi.org/10.1038/s41598-018-35133-9
  8. Stuppia G, Rizzo F, Riboldi G, et al. MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives. J Neurol Sci. 2015;356(1-2):7-18.  https://doi.org/10.1016/j.jns.2015.05.033
  9. Abati E, Manini A, Velardo D, et al. Clinical and genetic features of a cohort of patients with MFN2-related neuropathy. Sci Rep. 2022;12(1):6181. https://doi.org/10.1038/s41598-022-10220-0
  10. Hoyt W. Charcot-Marie-Tooth disease with primary optic atrophy; report of a case. Arch Ophthalmol. 1960;64:925-878.  https://doi.org/10.1001/archopht.1960.01840010927014
  11. Hamedani A, Wilson J, Avery R, Scherer S. Optic Neuropathy in Charcot-Marie-Tooth Disease. J Neuroophthalmol. 2021;41(2):233-238.  https://doi.org/10.1097/WNO.0000000000000965
  12. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth’s disease. Clin Genet. 1974;6(2):98-118.  https://doi.org/10.1111/j.1399-0004.1974.tb00638.x
  13. Pipis M, Feely S, Polke J, et al. Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study. Brain. 2020;143(12):3589-3602. https://doi.org/10.1093/brain/awaa323
  14. Rance G, Ryan M, Bayliss K, et al. Auditory function in children with Charcot-Marie-Tooth disease. Brain. 2012;135(Pt 5):1412-22.  https://doi.org/10.1093/brain/aws085
  15. Choi J, Seol H, Seok J, et al. Psychoacoustics and neurophysiological auditory processing in patients with Charcot-Marie-Tooth disease types 1A and 2A. Eur J Neurol. 2020;27(10):2079-2088. https://doi.org/10.1111/ene.14370
  16. Manzoor U, Ali A, Ali S, et al. Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: clinical insights and phenotypic effects. J Genet Eng Biotechnol. 2023;21(1):119.  https://doi.org/10.1186/s43141-023-00568-9
  17. Deng S, Feely S, Shi Y, et al. Incidence and Clinical Features of TRPV4-Linked Axonal Neuropathies in a USA Cohort of Charcot-Marie-Tooth Disease Type 2. Neuromolecular Med. 2020;22(1):68-72.  https://doi.org/10.1007/s12017-019-08564-4
  18. Zambon A, Natali Sora M, Cantarella G, et al. Vocal cord paralysis in Charcot-Marie-Tooth type 4b1 disease associated with a novel mutation in the myotubularin-related protein 2 gene: A case report and review of the literature. Neuromuscul Disord. 2017;27(5):487-491.  https://doi.org/10.1016/j.nmd.2017.01.006
  19. Bombelli F, Stojkovic T, Dubourg O, et al. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features. JAMA Neurol. 2014;71(8):1036-1042. https://doi.org/10.1001/jamaneurol.2014.629
  20. Ma Y, Sun A, Zhang Y, et al. The Genotype and Phenotype Features in a Large Chinese MFN2 Mutation Cohort. Front Neurol. 2021;12:757518. https://doi.org/10.3389/fneur.2021.757518
  21. Ando M, Hashiguchi A, Okamoto Y, et al. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study. J Peripher Nerv Syst. 2017;22(3):191-199.  https://doi.org/10.1111/jns.12228
  22. Calvo J, Funalot B, Ouvrier R, et al. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations. Arch Neurol. 2009;66(12):1511-1516. https://doi.org/10.1001/archneurol.2009.284
  23. Принята 12.02.2025 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.